Myc versus USF: Discrimination at the cad Gene Is Determined by Core Promoter Elements

REFERENCES

• Amati, B., M. W. Brooks, N. Levy, T. D. Littlewood, G. I. Evan, and H. Land. 1993. Oncogenic activity of the c-myc protein requires dimerization with Max. Cell 72:233–245.
   PubMed Web of Science ®Google Scholar
• Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359:423–426.
   PubMed Web of Science ®Google Scholar
• Angel, P., R. Imagawa, R. Chiu, B. Stein, H. J. Imbra, H. J. Rahmsorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739.
   PubMed Web of Science ®Google Scholar
• Aoki, T., and G. Weber. 1981. Carbamoyl phosphate synthetase (glutamine-hydrolyzing): increased activity in cancer cells. Science 212:463–465.
   PubMed Web of Science ®Google Scholar
• Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211–222.
   PubMed Web of Science ®Google Scholar
• Beckmann, H., L. Su, and T. Kadesch. 1990. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer µE3 motif. Genes Dev. 4:167–179.
   PubMed Web of Science ®Google Scholar
• Beijersbergen, R. L., E. M. Hijmans, L. Zhu, and R. Bernards. 1994. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13:4080–4086.
   PubMedGoogle Scholar
• Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804–7808.
   PubMed Web of Science ®Google Scholar
• Bendall, A. J., and P. L. Molloy. 1994. Base preferences for DNA binding by the bHLH-Zip protein USF: effects of MgCl2 on specificity and comparison with binding of Myc family members. Nucleic Acids Res. 22:2801–2810.
   PubMed Web of Science ®Google Scholar
• Benvenisty, N., A. Leder, A. Kuo, and P. Leder. 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6:2513–2523.
   PubMedGoogle Scholar
• Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA-binding by the c-Myc protein. Science 250:1149–1151.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211–1217.
   PubMed Web of Science ®Google Scholar
• Boyd, K. E. Unpublished results.
   Google Scholar
• Bucher, P. 1990. Weight matrix descriptions of four eucaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212:563–578.
   PubMed Web of Science ®Google Scholar
• Buermeyer, A. B., N. E. Thompson, L. A. Strasheim, R. R. Burgess, and P. J. Farnham. 1992. The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II. Mol. Cell. Biol. 12:2250–2259.
   PubMedGoogle Scholar
• Campisi, J., H. E. Gray, A. B. Pardee, M. Dean, and G. Sonenshein. 1984. Cell cycle control of c-myc but not c-ras is lost following chemical transformation. Cell 36:241–247.
   PubMed Web of Science ®Google Scholar
• Carr, C. S., and P. A. Sharp. 1990. A helix-loop-helix protein related to the immunoglobulin E box-binding proteins. Mol. Cell. Biol. 10:4384–4388.
   PubMed Web of Science ®Google Scholar
• Chiang, C.-M., and R. G. Roeder. 1995. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 267:531–536.
   PubMed Web of Science ®Google Scholar
• Desbarats, L., S. Gaubatz, and M. Eilers. 1996. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev. 10:447–460.
   PubMed Web of Science ®Google Scholar
• Eisenman, R. N., C. Y. Tachibana, H. D. Abrams, and S. R. Hann. 1985. v-myc and c-myc-encoded proteins are associated with the nuclear matrix. Mol. Cell. Biol. 5:114–126.
   PubMed Web of Science ®Google Scholar
• Farnham, P. J., and R. Kollmar. 1990. Characterization of the 5′ end of the growth-regulated syrian hamster CAD gene. Cell Growth Differ. 1:179–189.
   PubMedGoogle Scholar
• Feaver, W. J., J. Q. Svejstrup, N. L. Henry, and R. D. Kornberg. 1994. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79:1103–1109.
   PubMed Web of Science ®Google Scholar
• Fisher, F., D. H. Crouch, P.-S. Jayaraman, W. Clark, D. A. F. Gillespie, and C. R. Goding. 1993. Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo. EMBO J. 12:5075–5082.
   PubMedGoogle Scholar
• Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511–517.
   PubMed Web of Science ®Google Scholar
• Gaubatz, S., A. Meichle, and M. Eilers. 1994. An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc. Mol. Cell. Biol. 14:3853–3862.
   PubMedGoogle Scholar
• Gilmour, D. S., and J. T. Lis. 1985. In vivo interactions of RNA polymerase II with genes of Drosophila melanogaster. Mol. Cell. Biol. 5:2009–2018.
   PubMed Web of Science ®Google Scholar
• Grandori, C., J. Mac, F. Siebelt, D. E. Ayer, and R. N. Eisenman. 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15:4344–4357.
   PubMed Web of Science ®Google Scholar
• Gregor, P. D., M. Sawadogo, and R. G. Roeder. 1990. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev. 4:1730–1740.
   PubMed Web of Science ®Google Scholar
• Hateboer, G., H. T. Timmers, A. K. Rustgi, M. Billaud, L. J van’t Veer, and R. Bernards. 1993. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1 protein. Proc. Natl. Acad. Sci. USA 90:8489–8493.
   PubMedGoogle Scholar
• Heikkila, R., G. Schwab, E. Wickstrom, S. L. Loke, D. H. Pluznik, R. Watt, and L. M. Neckers. 1987. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature 328:445–449.
   PubMed Web of Science ®Google Scholar
• Jones, R. M., J. Branda, K. A. Johnston, M. Polymenis, M. Gadd, A. Rustgi, L. Callanan, and E. V. Schmidt. 1996. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol. Cell. Biol. 16:4754–4764.
   PubMed Web of Science ®Google Scholar
• Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
   PubMed Web of Science ®Google Scholar
• Kollmar, R., K. A. Sukow, S. K. Sponagle, and P. J. Farnham. 1994. Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hy-drolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. J. Biol. Chem. 269:2252–2257.
   PubMedGoogle Scholar
• Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596–602.
   PubMed Web of Science ®Google Scholar
• Li, L.-H., C. Nerlov, G. Prendergast, D. MacGregor, and E. B. Ziff. 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13:4070–4079.
   PubMedGoogle Scholar
• Liao, W. S. L., R. Heller, P. Green, and G. R. Stark. 1986. Regulation of carbamoyl phosphate synthetase-aspartate transcarbamoylase-dihydrooro-tase gene expression in growing and arrested cells. J. Biol. Chem. 261:15577–15581.
   PubMedGoogle Scholar
• Luo, X., and M. Sawadogo. 1996. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc. Natl. Acad. Sci. USA 93:1308–1313.
   PubMedGoogle Scholar
• Luo, X., and M. Sawadogo. 1996. Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains. Mol. Cell. Biol. 16:1367–1375.
   PubMedGoogle Scholar
• Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809–860.
   PubMed Web of Science ®Google Scholar
• McEwan, I. J., K. Dahlman-Wright, J. Ford, and A. P. H. Wright. 1996. Functional interactions of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. Biochemistry 35:9584–9593.
   PubMedGoogle Scholar
• Means, A. L., J. E. Slansky, S. L. McMahon, M. W. Knuth, and P. J. Farnham. 1992. The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol. Cell. Biol. 12:1054–1063.
   PubMedGoogle Scholar
• Miltenberger, R. J., J. Cortner, and P. J. Farnham. 1993. An inhibitory Raf-1 mutant suppresses expression of a subset of v-raf-activated genes. J. Biol. Chem. 268:15674–15680.
   PubMedGoogle Scholar
• Miltenberger, R. J., K. Sukow, and P. J. Farnham. 1995. An E box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527–2535.
   PubMed Web of Science ®Google Scholar
• Rao, G. N., E. S. Buford, and J. N. Davidson. 1987. Transcriptional regulation of the human CAD gene during myeloid differentiation. Mol. Cell. Biol. 7:1961–1966.
   PubMedGoogle Scholar
• Rao, G. N., and R. L. Church. 1988. Regulation of CAD gene expression in mouse fibroblasts during the transition from the resting to the growing state. Exp. Cell Res. 178:449–456.
   PubMedGoogle Scholar
• Rao, G. N., and J. N. Davidson. 1988. CAD gene expression in serum-starved and serum-stimulated hamster cells. DNA 7:423–432.
   PubMedGoogle Scholar
• Roy, B., J. Beamon, E. Balint, and D. Reisman. 1994. Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors. Mol. Cell. Biol. 14:7805–7815.
   PubMedGoogle Scholar
• Roy, R., J. P. Adamczewski, T. Seroz, W. Vermeulen, J.-P. Tassen, L. Schaef-fer, E. A. Nigg, J. H. J. Hoeijmakers, and J.-M. Egly. 1994. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79:1093–1101.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Slansky, J. E., Y. Li, W. G. Kaelin, and P. J. Farnham. 1993. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 13:1610–1618. (Erratum, 13:7201.)
   PubMed Web of Science ®Google Scholar
• Tobias, K. E., J. Shor, and C. Kahana. 1995. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs. Oncogene 11:1721–1727.
   PubMedGoogle Scholar
• Wagner, A. J., C. Meyers, L. A. Laimins, and N. Hay. 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:879–883.
   PubMedGoogle Scholar
• Wahl, G. M., R. A. Padgett, and G. R. Stark. 1979. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phospho-nacetyl)-L-aspartate-resistant hamster cells. J. Biol. Chem. 254:8679–8689.
   PubMedGoogle Scholar
• Walter, J., C. A. Dever, and M. D. Biggin. 1994. Two homeo domain proteins bind with similar specificity to a wide range of DNA sites in Drosophila embryos. Genes Dev. 8:1678–1692.
   PubMedGoogle Scholar
• Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223–232.
   PubMed Web of Science ®Google Scholar